Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Jeanie Herbert - Senior Director of Investor Relations and Corporate Communications Mark Foley - President and Chief Executive Officer Toby Schilke - Chief Financial Officer Dr. Abhay Joshi - Chief Operating Officer and President of R&D and Product Operations Dustin Sjuts - Chief Commercial Officer of Aesthetics and Therapeutics Conference Call Participants Jacob Hughes - Wells Fargo Securit ...